Metraipolis › archive › dc_47bf5c90d18f
Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer — Europe PMC PMID:41333367
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41333367
- DOI
- 10.3332/ecancer.2025.1966
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T14:56:55.278Z
- SHA-256 of the archived text
036be0043d25675f0d0ec71ccb0e8f29e478db1c45ca9d39c4c9035a9a0b0654- Stable URL of this page
https://metraipolis.com/documento/dc_47bf5c90d18f
How to cite
Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer — Europe PMC PMID:41333367 — Europe PMC (en), https://europepmc.org/article/MED/41333367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47bf5c90d18f (Metraipolis archive dc_47bf5c90d18f, sha256 036be0043d25675f0d0ec71ccb0e8f29e478db1c45ca9d39c4c9035a9a0b0654)
BibTeX
@misc{dc47bf5c90d18f,
title = {Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer — Europe PMC PMID:41333367},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41333367},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47bf5c90d18f; sha256 036be0043d25675f0d0ec71ccb0e8f29e478db1c45ca9d39c4c9035a9a0b0654},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333367. Agents can read the archived copy with the MCP tool read_document.